David L Goldblatt Selected Research

PAM2-CSK4

1/2020	Inducible epithelial resistance against acute Sendai virus infection prevents chronic asthma-like lung disease in mice.
1/2014	Safety, tolerability, and biomarkers of the treatment of mice with aerosolized Toll-like receptor ligands.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David L Goldblatt Research Topics

Disease

5	Pneumonia (Pneumonitis) 01/2023 - 01/2014
2	Inflammation (Inflammations) 01/2022 - 01/2020
2	Infections 12/2020 - 01/2020
1	Viral Pneumonia 12/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	Lung Diseases (Lung Disease) 01/2020
1	Asthma (Bronchial Asthma) 01/2020
1	Metaplasia 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 01/2014
1	Necrosis 01/2014
1	Weight Loss (Weight Reduction) 01/2014

Drug/Important Bio-Agent (IBA)

3	Toll-Like Receptor AgonistsIBA 01/2022 - 01/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 01/2023
2	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2023 - 01/2023
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 01/2023
2	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2020 - 01/2020
2	PAM2-CSK4IBA 01/2020 - 01/2014
1	AntioxidantsIBA 01/2023
1	salicylhydroxamic acid (SHAM)IBA 12/2020
1	Methacholine Chloride (Methacholine)FDA Link 01/2020
1	Interleukin-33IBA 01/2020
1	SugarsIBA 01/2014
1	Chemokine CXCL2IBA 01/2014
1	Biomarkers (Surrogate Marker)IBA 01/2014
1	LigandsIBA 01/2014
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2014
1	Interleukin-6 (Interleukin 6)IBA 01/2014
1	CytokinesIBA 01/2014

Therapy/Procedure

1	Therapeutics 01/2023
1	Immunomodulation 01/2022
1	Aftercare (After-Treatment) 01/2014